期刊文献+

肝硬化患者应用阿德福韦酯治疗导致低磷性软骨病1例 被引量:1

下载PDF
导出
摘要 慢性乙型肝炎(chronic hepatitis B,CHB)是全球性公共卫生问题[1,2],若不及时的抗病毒治疗可进展成肝硬化,甚至肝癌。为了减缓疾病的进展,抗病毒治疗是关键。阿德福韦酯以其相对低廉的价格和低耐药率在我国抗病毒药物的市场中占有重要的地位。我们报道1例肝硬化的患者在服用阿德福韦酯治疗导致低磷性骨病。
出处 《中国肝脏病杂志(电子版)》 CAS 2015年第2期111-112,共2页 Chinese Journal of Liver Diseases:Electronic Version
  • 相关文献

参考文献8

  • 1Lok AS, McMahon B1. Chronic hepatitis B: update of recommendations[J]. Hepatology,2004,39:857 -861.
  • 2Lai CL, Ratziu V, Yuen MF, et al. Viral hepatitis B[J]. Lancet, 2003,362:2089-2094.
  • 3Jung YK, Yeon JE, Choi JH, et al. Fanconi's syndrome associated with prolonged adefovir dipivoxil therapy in a hepatitis B virus patient[J]. Gut and Liver,2010,4:389-393.
  • 4Hamnvik OP, Becker CB, Levy BD, et al. Clinical problem-solving. Wasting away[J]. N Engl J Med,2014,370:959-966.
  • 5Hannon H, Bagnis CI, Benhamou Y, et al. The renal tolerance of lowdose adefovir dipivoxil by lamivudine-resistant individuals co-infected with hepatitis B and HIV[J]. Nephrol Dial Transplant,2004,19:386-390.
  • 6Izzedine H, Hulot JS, Launay- Vacher V, et al. Renal safety of adefovir dipivoxil in patients with chronic hepatitis B: two double-blind, randomized, placebo-controlled studies[J]. Kidney Int,2004,66:1153- 1158.
  • 7Jeong HJ, Lee JM, Lee TH, et al. Two Cases of Hypophosphatemic Osteomalacia After Long-term Low Dose Adefovir Therapy in Chronic Hepatitis B and Literature Review[J]. J Bone Metab,2014,21:76-83.
  • 8林清锋,潘凡,洪富源,潘晨.阿德福韦酯致Fanconi综合征及低磷性软骨病1例[J].中华肝脏病杂志,2014,22(10):779-780. 被引量:3

二级参考文献5

共引文献2

同被引文献19

  • 1Fontana RJ. Side effects of long-term oral antiviral therapy for hepatitis[J]. Hepatology,2009,4 9:185-195.
  • 2Izzedine H, Hulot JS, Launay-Vacher V, et al. Renal safety of adefovir dipivoxil in patients with chronic B:two doubleblind, randomized, placebo-controlled studies[J]. Kidney Int,2004.66:1153-1158.
  • 3Tamori A, Enomoto M, Kobayashi S, et al. Add-on combination therapy with adefovir dipivoxil induces renal impairment in patients with lamivudine-refractory hepatitis B virus[J]. J Viral Hepat,2010,17:123-129.
  • 4Wong T, Girgis CM, Ngu MC, et al. Hypophosphattemic osteomalacia after low-dose adefovir dipivoxil therapy for hepatitis B[J]. J Clin Endocrinol Metab,2010,95:479-480.
  • 5Kwon J, Ahn SY, Ko SY, et al. A case of osteomalacia related to adfovir in a patient with chronic hepatitis B[J]. Korean J Gastroenterol,2010,56:117-120.
  • 6Izzedine H, Launay-Vacher V, Deray G. Antiviral drug-induced nephrotoxicity[J]. Am J Kidney Dis,2005.45:804-817.
  • 7Bichet DG. Inherited disorders of the renal tubule/brenner BM. Brenaer & rector' s the kidney[M]. 8th ed. Philadelphia: Saunders,2008:1390-1393.
  • 8Kim DH, Sung DH, Min YK. Hypophosphatemic osteomalacia induced by low-dose adefovir therapy: focus on manifestations in the skeletal system and literature review[J]. J Bone Miner Metab,2013,31:240-246.
  • 9Kim YJ, Cho HC, Sinn DH, et al. Frequency and risk factors of renal impairment during long-term adefovir dipivoxil treatment in chronic hepatitis B patients[J]. J Gastroenterol Hepatol,2012,27:306-312.
  • 10Tanaka M, Suzuki F, Seko Y, et al. Renal dysfunction and hypophosphatemia during long-term lamivudine plus adefovir dipivoxil therapy in patients with chronic hepatitis B[J]. J Gastroenterol,2013,49:470-480.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部